Patient characteristics
| Patient characteristic . | Laser group . | Control group . |
|---|---|---|
| Age, y | ||
| Average | 36.5 | 36.8 |
| Median | 38.0 | 36.0 |
| Gender, n | ||
| Male | 12 | 11 |
| Female | 7 | 8 |
| HSCT, n | ||
| Related allogeneic | 11 | 9 |
| Related allogeneic with TBI | 0 | 2 |
| Unrelated allogeneic with TBI | 1 | 3 |
| Unrelated allogeneic umbilical cord blood cells with TBI | 2 | 0 |
| Autologous | 5 | 5 |
| Diagnostic, n | ||
| Chronic myeloblastic leukemia | 8 | 8 |
| Acute myeloblastic leukemia | 3 | 3 |
| Hodgkin lymphoma | 6 | 2 |
| Non-Hodgkin lymphoma | 1 | 3 |
| Acute lymphoblastic leukemia | 1 | 0 |
| Myelodysplastic syndrome | 0 | 3 |
| Patient characteristic . | Laser group . | Control group . |
|---|---|---|
| Age, y | ||
| Average | 36.5 | 36.8 |
| Median | 38.0 | 36.0 |
| Gender, n | ||
| Male | 12 | 11 |
| Female | 7 | 8 |
| HSCT, n | ||
| Related allogeneic | 11 | 9 |
| Related allogeneic with TBI | 0 | 2 |
| Unrelated allogeneic with TBI | 1 | 3 |
| Unrelated allogeneic umbilical cord blood cells with TBI | 2 | 0 |
| Autologous | 5 | 5 |
| Diagnostic, n | ||
| Chronic myeloblastic leukemia | 8 | 8 |
| Acute myeloblastic leukemia | 3 | 3 |
| Hodgkin lymphoma | 6 | 2 |
| Non-Hodgkin lymphoma | 1 | 3 |
| Acute lymphoblastic leukemia | 1 | 0 |
| Myelodysplastic syndrome | 0 | 3 |
TBI indicates total body irradiation.